Get the Stockscreener App
2.71
35.00%
0.71
Immunoprecise Antibodies Ltd stock is traded at $2.71, with a volume of 9.47M.
It is up +35.00% in the last 24 hours and up +56.07% over the past month.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.
See More
Previous Close:
$2.00
Open:
$2.02
24h Volume:
9.47M
Relative Volume:
3.80
Market Cap:
$124.62M
Revenue:
$16.77M
Net Income/Loss:
$-11.87M
P/E Ratio:
-5.7149
EPS:
-0.4742
Net Cash Flow:
$-5.90M
1W Performance:
+42.11%
1M Performance:
+56.07%
6M Performance:
+526.74%
1Y Performance:
+164.71%
1-Day Range:
$2.0016
$2.70
1-Week Range:
$1.8146
$2.68
52-Week Range:
$0.30
$2.68
Immunoprecise Antibodies Ltd Stock (IPA) Company Profile
Name
Immunoprecise Antibodies Ltd
Sector
Industry
Phone
-
Address
-
Compare IPA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPA
Immunoprecise Antibodies Ltd
|
2.70 | 92.31M | 16.77M | -11.87M | -5.90M | -0.4742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.15 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.37 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
457.33 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.90 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
319.55 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Oct-25-21 | Initiated | The Benchmark Company | Buy |
Immunoprecise Antibodies Ltd Stock (IPA) Latest News
Is ImmunoPrecise Antibodies Ltd. stock bottoming outOptions Play & Community Consensus Picks - Newser
Historical volatility pattern of ImmunoPrecise Antibodies Ltd. visualizedJuly 2025 Highlights & Real-Time Volume Analysis - Newser
Visual analytics tools that track ImmunoPrecise Antibodies Ltd. performanceJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - Newser
Is ImmunoPrecise Antibodies Ltd. forming a reversal pattern2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Risk vs reward if holding onto ImmunoPrecise Antibodies Ltd.Trade Entry Report & Step-by-Step Swing Trade Plans - Newser
Strategies to average down on ImmunoPrecise Antibodies Ltd.Trade Ideas & Weekly Hot Stock Watchlists - Newser
Is ImmunoPrecise Antibodies Ltd. stock ready for a breakoutTrade Risk Assessment & Long Hold Capital Preservation Plans - Newser
Published on: 2025-08-15 09:47:46 - sundaytimes.kr
ImmunoPrecise Antibodies Ltd. Added to Custom Quant Screener TodayDip Buying & Weekly Momentum Picks - beatles.ru
ImmunoPrecise Antibodies Ltd. Reaches Critical Trendline SupportJuly 2025 Rallies & Daily Profit Maximizing Tips - beatles.ru
ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading 8.1% Higher – Here’s Why - Defense World
Is ImmunoPrecise Antibodies Ltd. stock a good hedge against inflationFree Technical Entry Strategy for Beginners - Newser
ImmunoPrecise Antibodies Maintains Buy Rating on Strong Canadian Growth and Strategic Divestment - AInvest
AVS Bio Expands Capabilities in Antibody Discovery and Protein Production with Acquisition of ImmunoPrecise Antibodies Europe - AInvest
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities with Acquisition of ImmunoPrecise Antibodies Europe from ImmunoPrecise Antibodies Ltd. - MarketScreener
Immunic, Inc. shares fall 1.43% after-hours as ImmunoPrecise Antibodies Ltd. reports earnings miss and auditor raises 'going concern' doubt. - AInvest
Angi (ANGI) Q2 Revenue Beats by 6% - AOL.com
Inmune Bio Inc. shares fall 1.09% after-hours as ImmunoPrecise Antibodies Ltd. reports earnings miss and auditor raises 'going concern' doubt. - AInvest
Sensei (SNSE) Q2 Loss Narrows 31% - AOL.com
Aurinia (AUPH) Q2 Revenue Jumps 22% - AOL.com
ImmunoPrecise Antibodies Divests Netherlands Facilities to AVS Bio - citybiz
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2025 Earnings Call Transcript - MSN
Beta Bionics (BBNX) Q2 Revenue Soars 54% - AOL.com
ImmunoPrecise Antibodies divests Netherlands facilities to AVS Bio - MSN
AVS Bio, an Arlington Capital Partners Portfolio Co. Acquires ImmunoPrecise Antibodies Europe - citybiz
ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation - Silicon Canals
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd. - Silicon Canals
ImmunoPrecise Antibodies Divests Dutch Subsidiary to Focus on AI Innovation - TipRanks
ImmunoPrecise Antibodies sells Netherlands subsidiary to AVS Bio for $12m - Investing.com Australia
TR | OpenAI4o Initiates ImmunoPrecise Antibodies(IPA.US) With Hold Rating, Announces Target Price $2 - 富途牛牛
Day One (DAWN) Q2 Revenue Jumps 313% - AOL.com
Prothena Q2 Revenue Drops 97% - AOL.com
ImmunoPrecise Antibodies (NASDAQ:IPA) Upgraded at Wall Street Zen - Defense World
Agilon Health (AGL) Q2 Revenue Falls 6% - AOL.com
ImmunoPrecise (IPA) Q4 2025 Earnings Transcript - AOL.com
ITRM Reports Results - AOL.com
Idexx (IDXX) Q2 Revenue Jumps 11% - AOL.com
What Are You Thinking About Investing In ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) Stock? - stocksregister.com
What institutional investors are buying ImmunoPrecise Antibodies Ltd. stockUnstoppable trading performance - Jammu Links News
What catalysts could drive ImmunoPrecise Antibodies Ltd. stock higher in 2025High-yield market plays - Jammu Links News
ImmunoPrecise Antibodies Ltd. Stock Analysis and ForecastSuperior risk-adjusted returns - Jammu Links News
What are analysts’ price targets for ImmunoPrecise Antibodies Ltd. in the next 12 monthsDynamic growth stocks - Jammu Links News
What drives ImmunoPrecise Antibodies Ltd. stock priceTremendous wealth creation - Jammu Links News
What is ImmunoPrecise Antibodies Ltd. company’s growth strategyExtraordinary market timing - Jammu Links News
What makes ImmunoPrecise Antibodies Ltd. stock price move sharplyInvest smarter with advanced market data - Jammu Links News
What are the latest earnings results for ImmunoPrecise Antibodies Ltd.Build a diversified portfolio for maximum returns - Jammu Links News
ImmunoPrecise Antibodies Announces October 2025 Annual Meeting Details - AInvest
Why is ImmunoPrecise Antibodies Ltd. stock attracting strong analyst attentionWealth Building Planner With Proven Results - Jammu Links News
ImmunoPrecise Antibodies Announces Details for October 2025 Annual Meeting - TipRanks
Does ImmunoPrecise Antibodies Ltd. stock perform well during market downturnsFinancial News Updates For Consistent Profits - Jammu Links News
What does recent volatility data suggest for ImmunoPrecise Antibodies Ltd.Technical Entry Plan with Risk Minimization - Newser
Immunoprecise Antibodies Ltd Stock (IPA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):